Skip to content
10-Q

Quarterly Report

DERMA SCIENCES, INC.

0001144204-16-100505

← back to feed
Filed
May 10, 2016 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2016 · May 9, 2016 25.89M sh
Capex Q1 2016 · Mar 31, 2016 $107.75K
Capex Q1 2016 · Mar 31, 2015 $433.14K
Short Term Investments Q1 2016 · Mar 31, 2016 $25M
Short Term Investments Q1 2016 · Dec 31, 2015 $25M
Cash And Equivalents Q1 2016 · Mar 31, 2016 $11.78M
Cash And Equivalents Q1 2016 · Dec 31, 2015 $15.81M
Cash And Equivalents Q1 2016 · Mar 31, 2015 $16.5M
Cash And Equivalents Q1 2016 · Dec 31, 2014 $19.4M
Stockholders Equity Q1 2016 · Mar 31, 2016 $99.69M
Stockholders Equity Q1 2016 · Dec 31, 2015 $98.43M
Current Liabilities Q1 2016 · Mar 31, 2016 $10.58M
Current Liabilities Q1 2016 · Dec 31, 2015 $13.54M
Total Liabilities Q1 2016 · Mar 31, 2016 $14.22M
Total Liabilities Q1 2016 · Dec 31, 2015 $16.35M
Current Assets Q1 2016 · Mar 31, 2016 $67.79M
Current Assets Q1 2016 · Dec 31, 2015 $71.1M
Total Assets Q1 2016 · Mar 31, 2016 $113.91M
Total Assets Q1 2016 · Dec 31, 2015 $114.78M
Rd Expense Q1 2016 · Mar 31, 2016 $0
Rd Expense restated Q1 2016 · Mar 31, 2015 $352.18K
Net Income Q1 2016 · Mar 31, 2016 −$1.76M
Net Income Q1 2016 · Mar 31, 2015 −$10.61M
Operating Income Q1 2016 · Mar 31, 2016 −$2.25M
Operating Income restated Q1 2016 · Mar 31, 2015 −$6.08M
Gross Profit Q1 2016 · Mar 31, 2016 $7.71M
Gross Profit Q1 2016 · Mar 31, 2015 $7.54M
Cost Of Revenue Q1 2016 · Mar 31, 2016 $12.54M
Cost Of Revenue Q1 2016 · Mar 31, 2015 $11.96M